These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1903660)

  • 1. Skin conductance activity after intraventricular administration of 6-hydroxydopa in rats.
    Yamamoto K; Hoshino T; Takahashi Y; Kaneko H; Ozawa N
    Biol Psychiatry; 1991 Feb; 29(4):365-75. PubMed ID: 1903660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential changes of skin conductance activity in rats after intraventricular administration of 6-hydroxydopamine.
    Yamamoto K; Kaneko H
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(6):723-8. PubMed ID: 3101137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional influence of the central noradrenergic system on the skin conductance activity in rats.
    Yamamoto K; Ozawa N; Shinba T; Hoshino T
    Schizophr Res; 1994 Sep; 13(2):145-50. PubMed ID: 7986771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two types of changes in skin conductance activity after intraventricular administration of 6-hydroxydopamine in rats.
    Yamamoto K; Kiyosumi H; Yamaguchi K; Moroji T
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(3):245-50. PubMed ID: 3929330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin conductance response after 6-hydroxydopamine lesion of central noradrenaline system in cats.
    Yamamoto K; Arai H; Nakayama S
    Biol Psychiatry; 1990 Jul; 28(2):151-60. PubMed ID: 2165823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Habituation failure of skin conductance response after intraventricular administration of 6-hydroxydopamine in cats.
    Yamamoto K; Hagino K; Moroji T; Ishii T
    Experientia; 1984 Apr; 40(4):344-5. PubMed ID: 6425074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin conductance responding in schizophrenic patients with abnormal involuntary movements.
    Mintz M; Alfisi S; Sigal M
    Psychiatry Res; 1990 Oct; 34(1):19-27. PubMed ID: 1980017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental localization of noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Dev Neurosci; 1982; 5(2-3):252-62. PubMed ID: 6813097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Habituation of skin conductance response in a methadone population.
    Loimer N; Jagsch R; Linzmayer L; Grünberger J
    Drug Alcohol Depend; 1990 Oct; 26(2):199-202. PubMed ID: 2242722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal Lesioning and Lifelong Effects of the Noradrenergic Neurotoxin 6-Hydroxydopa.
    Kostrzewa RM
    Curr Top Behav Neurosci; 2016; 29():43-50. PubMed ID: 26660536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain.
    Kostrzewa RM; Garey RE
    J Pharmacol Exp Ther; 1976 Apr; 197(1):105-18. PubMed ID: 1263125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
    Kantak KM; Hegstrand LR; Eichelman B
    Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an opioid-specific action of morphine in modifying recovery of neonatally-damaged noradrenergic fibers in rat brain.
    Kostrzewa RM; Klisans-Fuenmayor D
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):3-11. PubMed ID: 6438742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal 6-hydroxydopa, but not DSP-4, elevates brainstem monoamines and impairs inhibitory avoidance learning in developing rats.
    Cornwell-Jones CA; Decker MW; Chang JW; Cole B; Goltz KM; Tran T; McGaugh JL
    Brain Res; 1989 Jul; 493(2):258-68. PubMed ID: 2504438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of central noradrenergic system in thyrotropin-releasing hormone-induced behavioral excitement in 6-OHDOPA-treated, infant rats.
    Oki K; Nomura Y; Segawa T
    J Pharmacobiodyn; 1982 Sep; 5(9):716-9. PubMed ID: 6818336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of immobilization stress on electrodermal activity and brain catecholamine levels in rats.
    Süer C; Ozesmi C; Temoçin S; Doğan P; Ciliv G
    Int J Neurosci; 1992; 65(1-4):91-101. PubMed ID: 1341695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sensory filter in schizophrenia: a study of habituation, arousal, and the dopamine hypothesis.
    Horvath T; Meares R
    Br J Psychiatry; 1979 Jan; 134():39-45. PubMed ID: 760922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor.
    Kostrzewa RM; Brus R
    Amino Acids; 1998; 14(1-3):175-9. PubMed ID: 9871458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin conductance reaction (SCR)-habituation test, a tool to detect anxiolytic activity. Its justification by the correlation between SCR-habituation test activities and specific binding potencies in benzodiazepines.
    Marcy R; Quermonne MA; Raoul J; Nammathao B; Smida A
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):387-91. PubMed ID: 2866560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate-enhanced toxicity and noradrenergic sprouting in rats treated with 6-hydroxydopa.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Eur J Pharmacol; 1981 May; 71(4):365-73. PubMed ID: 6788574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.